An Nvidia logo is seen on the company building in an industrial park February 7, 2019 in Tianjin, China.
VCG | China Visual Group | Getty Images
CureVac – Shares of the German biopharmaceutical company continued to decline after it released the main efficacy results for its Covid-19 vaccine candidate on Wednesday, which demonstrated an interim efficacy of just 47%. The stock is trading down around 40% at noon.
Novavax – After CureVac reported disappointing results from a study of its Covid-19 vaccine, shares of Novavax increased by 2%. Novavax said on Monday that its Covid vaccine is 90% effective.
The Honest Company – Shares of The Honest Company fell 9% after the beauty and baby store’s first earnings report. The company reported first-quarter revenue of $ 81.0 million, compared to $ 79.3 million estimated by analysts, according to Refinitiv. Guggenheim lowered the title to neutral buying. “While we remain positive on the underlying fundamental outlook, we are downgrading stocks to NEUTRAL given the more balanced risk / reward ratio and the absence of an apparent catalyst, in our view, to significantly raise our expectations of Prime. plan or our valuation multiple, ”Guggenheim said. mentionned.
Nvidia – Shares of Nvidia gained more than 4% after Jefferies raised its semiconductor price target to a Wall Street high of $ 712.41. “We see NVDA as a major beneficiary of the 4th Tectonic Shift in Computing, in which parallel processing captures a share of the computing market,” said Mark Lipacis of Jefferies. “We believe that NVDA’s investment in CUDA over the past ten years has resulted in a competitive advantage over several years.”
Lennar – Shares of the residential construction company were up about 2% at midday. Lennar reported earnings of $ 2.65 per share on Wednesday, beating estimates of $ 2.36 per share, according to Refinitiv. The company faces higher input costs and a labor shortage, but the lack of homes for sale in the United States has helped drive up prices and dramatically increase Lennar’s profit margins. compared to the previous year.
Danaher – Shares of the medical device maker rose about 4.5% after announcing it would buy privately-held biotech company Aldevron for $ 9.6 billion in an all-cash deal. Aldevron produces plasmid DNA, mRNA and proteins to assist biotech and pharmaceutical customers and has entered into an agreement with Moderna to supply plasmid DNA, a requirement for the manufacture of vaccines.
Kroger – Shares of the supermarket chain rose more than 4% after posting profits, raising its earnings forecast and increasing buybacks. Kroger reported earnings per share of $ 1.19, beating analyst estimates by 19%, and revenue of $ 41.3 billion.
Fisker – The automaker’s shares rose more than 2% by noon after finalizing a long-term manufacturing deal with Magna International. Production of the Fisker Ocean SUV is slated to begin in November 2022 at Magna’s carbon-neutral plant in Graz, Austria.
– CNBC’s Hannah Miao and Maggie Fitzgerald contributed reporting
Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews, and access to CNBC TV.
Register to start a free trial today